THE ACADEMY FOR CLINICAL DEBATES & CONTROVERSIES IN MEDICINE. Budapest, Hungary April 4-7, 2013 SPONSORSHIP AND EXHIBITION.

Transcription

1 THE ACADEMY FOR CLINICAL DEBATES & CONTROVERSIES IN MEDICINE The 4 th World Congress on CONTROVERSIES IN OPHTHALMOLOGY Anterior Segment Glaucoma Retina SPONSORSHIP AND EXHIBITION Prospectus Last Update: October 9, cophy@comtecmed.com

2 Invitation for the Sponsors We are pleased to announce the 4 th World Congress on Controversies in Ophthalmology (COPHy), which will take place in Budapest, Hungary, April 4-7, The highly successful 1 st, 2 nd and 3 rd COPHy Congresses, which took place in Prague, Barcelona, and Istanbul respectively, attracted over 2,000 participants from 58 countries. Based on the success of the COPHy congresses, and on the feedback from COPHy participants, COPHy Budapest will be devoted to evidence-based debates and discussions amongst chairpersons, speakers and the audience, all of whom will examine and analyze the most relevant issues raised during the course of 2012 within the field of Ophthalmology. In 2013 we will continue to emphasis Retina, Anterior Segment and Glaucoma sections, and we will also discuss at large burning issues in Ophthalmology. We invite you to participate in the 4 th World Congress of Controversies in Ophthalmology (COPHy), the next edition of many future congresses to come. As always, there are several opportunities and industry sponsored activities that we shall be happy to tailor suggestions for your needs. We cordially invite you to join us as sponsors and partners of COPHy 2013 in the beautiful city of Budapest, where Buda and Pest reach a consensus. Sincerely, Prof. Neil Bressler Prof. Anat Loewenstein Co-Chairpersons

3 CONGRESS PROFILE Since its launch in 2010, COPHy is establishing itself as a unique educational meeting where physicians can meet with outstanding experts in major Ophthalmology fields, and be updated on the most pressing clinical questions of the day. COPHy is the only annual congress of its kind that focuses mainly on controversial issues. Aims of the Congress To provide the insights into major changes in the rapidly evolving field of Ophthalmology. To provide an effective forum for discussing and debating unsolved issues by allowing ample time for speakers/audience discussion. To promulgate ethics and standards of practice and treatment To bridge gaps between expansion of basic science and information, and their consolidation into clinical practice To make it possible for the industry to meet the outstanding experts in the field, and to update international participants on pressing clinical and technological questions of the day. Past Congresses statistics COPHy Sessions 26 (including 26 (including 26 (including 3 symposia) 2 symposia) 5 symposia) Debates Faculty Poster Presentations Countries Demographics [ 3 ]

4 CONGRESS PROFILE Demographics CO-CHAIRPERSONS Neil Bressler, USA Anat Loewenstein, Israel Jorge Alio, Spain Anthony Arnold, USA Bekir Sitki Aslan, Turkey Ehud Assia, Israel Francisco Bandello, Italy Mauizio Battaglia Parodi, Italy Zsolt Biro, Hungary Bahram Bodaghi, France Stefano Bonini, Italy Francesco Boscia, Italy Neil Bressler, USA Susan Bressler, USA Massimo Busin, USA Louis Cantor, USA Usha Chakravarthy, UK Faculty (preliminary list) Beatrice Cochener, France Francesca Cordeiro, UK Gabriel Coscas, France Harminder Dua, UK Bora Eldem, Turkey Giampaolo Gini, Italy Anders Heijl, Sweden Gabor Hollo, Hungary Douglas A. Jabs, USA Jay Katz, USA Anat Kesler, Israel Ferenc Kuhn, USA Baruch Kuppermann, USA Paolo Lanzetta, Italy Andrew Lee, USA Anat Loewenstein, Israel William Mieler, USA Neil Miller, USA Joseph Moisseiev, Israel Zoltan Nagy, Hungary Peter Netland, USA Zsuzsa Recsan, Hungary Nachum Rosen, Israel Dan Sachs, Israel Hendrik Scholl, USA Wolfgang Schrader, Germany Judit Somlai, Hungary Gisele Soubrane, France E. Souied, France Walter J. Stark, USA Gustavo Tamayo, Colombia [ 4 ]

5 TIMETABLE 19:00 Welcome Reception Thursday, April 4, 2013 Friday, April 5, 2013 Hall A Hall B Hall C 08:30-10:00 Retina I: Imaging Glaucoma I: Medication Anterior Segment I: Cataract 10:00-10:30 Refreshment Break, Poster Viewing and Visit Exhibits 10:30-11:45 Plenary I 11:45-13:00 Plenary II 13:00-14:00 Lunch Break and Visit Exhibits 14:00-15:30 Retina II: Diabetic Glaucoma II: Laser Anterior Segment II: macular Edema Cornea 15:30-16:00 Refreshment Break, Poster Viewing and Visit Exhibits 16:00-17:30 Retina III: Neovascular AMD Neuro-Ophthalmology I Pediatric Ophthalmology Saturday, April 6, 2013 Hall A Hall B Hall C 08:30-10:00 Retina IV: Proliferative Glaucoma III: Surgery Anterior Segment III: Diabetic Retinopathy Refractive Surgery 10:00-10:30 Refreshment Break, Poster Viewing and Visit Exhibits 10:30-11:45 Plenary III 11:45-13:00 Plenary IV 13:00-14:00 Lunch Break and Visit Exhibits 14:00-15:30 Retina V: Retinal Vein Trauma Uveitis Occlusion 15:30-16:00 Refreshment Break, Poster Viewing and Visit Exhibits 16:00-17:30 Retina VI: Surgery Neuro-Ophthalmology II New Players Travel Day Sunday, April 7, 2013 [ 5 ]

6 08:30-10:00 Retina I Imaging and Genetics PRELIMINARY PROGRAM Friday, April 5, 2013 Hall A 08:30-09:00 Debate: Role of ICG angiography 08:30-08:40 Pro 08:40-08:50 Con 08:50-09:00 Final discussion with panel: All Speakers 09:00-09:30 Debate: Features in SD-OCT imaging other than retinal thickness to guide therapy 09:00-09:10 Retinal thickness sufficient 09:10-09:20 No, other features important 09:20-09:30 Final discussion with panel: All Speakers 09:30-10:00 Debate: The role of genetics in AMD progression 09:30-09:40 Genetics play a major role in AMD progression 09:40-09:50 Genetics do not add to the morphological findings 09:50-10:00 Final discussion with panel: All speakers 10:00-10:30 Refreshment Break, Poster Viewing and Visit Exhibits 14:00-15:30 Retina II Diabetic Macular Edema Capsule: Diabetic macular edema multiple optional treatments 14:00-14:45 Debate: Management of center-involved DME and 20/20 14:00-14:15 Laser 14:15-14:30 Anti-VEGF 14:30-14:45 Observation until worsening 14:45-15:05 Debate: Management of center-involved DME and 20/50 in pseudophake? 14:45-14:55 Corticosteroids 14:55-15:05 Anti-VEGF 15:05-15:25 Debate: If Ranibizumab for DME, 0.3 mg or 0.5 mg? 15:05-15: mg 15:15-15: mg 15:25-15:30 Discussion 15:30-16:00 Refreshment Break, Poster Viewing and Visit Exhibits 16:00-17:30 Retina III Neovascular AMD Capsule: Management of neovascular AMD 16:00-16:45 Debate: Which anti-vegf product? 16:00-16:10 Aflibercept 16:10-16:20 Bevacizumab 16:20-16:30 Ranibizumab 16:30-16:45 Discussion 16:45-17:15 Debate: Which regimen: PRN vs. Fixed regimen? 16:45-17:00 PRN regimen 17:00-17:15 Fixed regimen 17:15-17:30 Discussion 17:15-17:30 Debate: Are post-injection antibiotics recommended? 17:15-17:20 Yes 17:20-17:25 No 17:25-17:30 Discussion [ 6 ]

7 PRELIMINARY PROGRAM Saturday, April 6, 2013 Hall A 08:30-10:00 Retina IV Proliferative Diabetic Retinopathy Capsule: Advancing in the treatment of PDR 08:30-09:15 Debate: Management of PDR: PRP monotherapy vs. Intravitreal injections (±PRP) 08:30-08:45 PRP monotherapy 08:45-09:00 Intravitreal injections (±PRP) 09:00-09:15 Final discussion with panel: All Speakers 09:15-10:00 Debate: Does anti-vegf increase risk of traction retinal detachment? 09:15-09:30 Yes 09:30-09:45 No 09:45-10:00 Final discussion with panel: All Speakers 10:00-10:30 Refreshment Break, Poster Viewing and Visit Exhibits 14:00-15:30 Retina V Retinal Vein Occlusion Capsule: Management of retinal vein occlusion with macular edema 14:00-14:45 Debate: Management of macular edema from branch retinal vein occlusion 14:00-14:15 Anti-VEGF 14:15-14:30 Corticosteroids 14:30-14:45 Observation until worsening or no improvement 14:45-15:30 Debate: Anti-VEGF drugs for macular edema from central retinal vein occlusion 14:45-14:55 Aflibercept 14:55-15:05 Bevacizumab 15:05-15:15 Ranibizumab 15:15-15:30 Discussion 15:30-16:00 Refreshment Break, Poster Viewing and Visit Exhibits 16:00-17:30 Retina VI Surgery Session pending [ 7 ]

8 PRELIMINARY PROGRAM Friday, April 5, 2013 Hall B 08:30-10:00 Glaucoma I Medication 08:30-09:00 Debate: The trouble with Glaucoma medications 08:30-08:40 Critical effect 08:40-08:50 Minimal impact 08:50-09:00 Discussion 09:00-09:30 Debate: Nocturnal IOP critical in drug evaluation 09:00-09:10 Yes 09:10-09:20 No 09:20-09:30 Discussion 09:30-10:00 Debate: Next step in medical therapy 09:30-09:40 Neuroprotection 09:40-09:50 Alternative route (non-drop) 09:50-10:00 Discussion 10:00-10:30 Refreshment Break, Poster Viewing and Visit Exhibits 14:00-15:30 Glaucoma II Laser 14:00-14:30 Debate: First-line therapy 14:00-14:10 Medication 14:10-14:20 Laser trabeculoplasty 14:20-14:30 Discussion 14:30-15:00 Debate: Prostaglandins & Laser trabeculoplasty are additive 14:30-14:40 Yes 14:40-14:50 No 14:50-15:00 Discussion 15:00-15:30 Debate: Emphasis on effective IOP control? 15:00-15:10 Underutilized 15:10-15:20 Avoid 15:20-15:30 Discussion 15:30-16:00 Refreshment Break, Poster Viewing and Visit Exhibits [ 8 ]

9 08:30-10:00 Glaucoma III Surgery PRELIMINARY PROGRAM Saturday, April 6, 2013 Hall B 08:30-09:00 Debate: Trabeculectomy: Passé or gold standard? 08:30-08:40 Passé, compared to express, canaloplasty and tube shunts 08:40-08:50 Gold standard 08:50-09:00 Discussion 09:00-09:30 Debate: Ab Interno procedures (Trabectome and istent) are dawn of a new era 09:00-09:10 Yes 09:10-09:20 No 09:20-09:30 Discussion 09:30-10:00 Debate: Better diagnostic tests for glaucoma or better screening efforts? 09:30-09:40 Yes 09:40-09:50 No 09:50-10:00 Discussion 10:00-10:30 Refreshment Break, Poster Viewing and Visit Exhibits Friday, April 5, 2013 Hall C 08:30-10:00 Anterior Segment I Cataract: Clinical Femtosecond Cataract Surgery 08:30-09:10 Debate: Multifocal IOLs 08:30-08:40 Advantages of MF IOLs found in my practice 08:40-08:50 A degraded vision 08:50-09:00 When and how to exchange multifocal and other premium IOL s 09:00-09:10 Discussion 09:10-09:40 Debate: Femtosecond cataract surgery 09:10-09:20 Pro 09:20-09:30 Too early to use on large scale 09:30-09:40 Discussion 09:40-09:55 Management of dislocated IOL s 09:55-10:00 Discussion 10:00-10:30 Refreshment Break, Poster Viewing and Visit Exhibits [ 9 ]

10 14:00-15:30 Anterior Segment II Cornea PRELIMINARY PROGRAM 14:00-14:40 Debate: Astigmatism management 14:00-14:10 Keratotomy 14:10-14:20 LASIK 14:20-14:30 Toric IOL 14:30-14:40 Discussion 14:40-15:05 Debate: Dormant corneal ulcers 14:40-14:50 AMT best 14:50-15:00 Corneal biological stimulation 15:00-15:05 Discussion Friday, April 5, 2013 Hall C 15:05-15:30 Debate: Anterior Lamellar keratoplasty 15:05-15:15 Lamellar keratoplasty is the best option in most cases 15:15-15:25 Other less invasive options may be better (ICRS, CCL, combined procedures) 15:25-15:30 Discussion 15:30-16:00 Refreshment Break, Poster Viewing and Visit Exhibits 08:30-10:00 Anterior Segment III Refractive Surgery 08:30-09:15 Debate: Dry eye in lasik 08:30-08:45 Prevention is better 08:45-09:00 Treatment is better 09:00-09:15 Discussion Saturday, April 6, 2013 Hall C 09:15-10:00 Debate: Refractive surgery in keratoconus 09:15-09:30 Intraocular lenses 09:30-09:45 Excimer laser 09:45-10:00 Discussion 10:00-10:30 Refreshment Break, Poster Viewing and Visit Exhibits [ 10 ]

11 PRELIMINARY PROGRAM 16:00-17:30 Neuro-Ophthalmology I Friday, April 5, 2013 Hall B 16:00-16:20 Is there any treatment for NAION? a) Steroids b) Hemodilution c) Intravitreal bevacizumab/ranibizumab d) Erythropoietin e) Conclusion 16:20-16:45 Pseudotumor cerebri, idiopathic intracranial hypertension and venous sinus stenosis 1. In a patient with typical IIH, do you get an MRV? 2. If the MRV shows VST, how do you treat the patient? a) If the patient has moderate papilledema but no optic neuropathy 1) Medical therapy 2) Stenting b) If the patient has moderate papilledema with evidence of an optic neuropathy 1) Medical therapy 2) Non-stent surgery (eg, ONSF, shunt) 3) Stenting c) For those who stent, does your decision depend on what happens after you lower ICP? d) For those who stent, does it matter if there is a gradient? e) Conclusion 16:45-17:30 Case Presentations 1) Child with congenital nystagmus (classification and treatment options) 2) Older adult with isolated esotropia and abduction weakness 3) Young adult woman with acute optic neuritis (initial eval, treatment; recurrence issue) 4) Young adult woman with bilateral steroid-sensitive, steroid-dependent optic neuritis 5) Older adult with acute CRAO 6) Young man with LHON (as well as patient s asymptomatic brother) 7) Elderly woman with acute diplopia, scalp tenderness, and fatigue [ 11 ]

12 PRELIMINARY PROGRAM 16:00-17:30 Neuro-Ophthalmology II Saturday, April 6, 2013 Hall B 16:00-16:20 Is there any treatment for traumatic optic neuropathy? a) Steroids (including how much) b) Treat with surgery (immediately? After steroids? After time?) c) Other d) There is no treatment e) Conclusions 16:20-16:40 What is the optimum treatment for ocular myasthenia gravis? a) Mestinon b) Systemic steroids c) Non-steroidal immunosuppressive agent (eg, Cellcept, Imuran) (with or without steroids) d) Conclusions 16:40-17:30 Case Presentations 1) A child with chiasmal glioma 2) A young adult with NAION 3) An older adult with NAION on amiodarone 4) An older adult with NAION who used an erectile dysfunction drug the night before 5) An older adult with NAION and obstructive sleep apnea 6) An older adult with recurrent NAION 7) Threshold for treating a middle-aged woman with a presumed optic nerve sheath meningioma 8) A child with Horner syndrome 16:00-17:30 Pediatric Ophthalmology Session pending Friday, April 5, 2013 Hall C [ 12 ]

13 14:00-15:30 Trauma PRELIMINARY PROGRAM Saturday, April 6, 2013 Hall B 14:00-14:30 Debate: The timing of reconstructive surgery in open-globe trauma 14:00-14:05 Introduction 14:05-14:12 The case for comprehensive primary vitrectomy 14:12-14:19 The case for a staged approach 14:19-14:30 Discussion and conclusion 14:30-14:45 Update Lecture: The management of traumatic subluxation of the crystalline lens Discussion with audience 14:45-15:00 Update Lecture: The management of traumatic optic neuropathy Discussion with audience 15:00-15:30 Panel Discussion Case presentation Panel All Speakers 15:30-16:00 Refreshment Break, Poster Viewing and Visit Exhibits 14:00-15:30 Uveitis Saturday, April 6, 2013 Hall C 14:00-14:45 Debate: Ocular toxoplasmosis: Should all patients be treated? 14:00-14:15 Yes 14:15-14:30 No 14:30-14:45 Discussion 14:45-15:30 Debate: JIA-associated chronic uveitis: Is chronic topical corticosteroid therapy ever acceptable treatment? 14:45-15:00 Yes 15:00-15:15 No 15:15-15:30 Discussion 15:30-16:00 Refreshment Break, Poster Viewing and Visit Exhibits 16:00-17:30 New Players Session pending Saturday, April 6, 2013 Hall C [ 13 ]

14

15 CATEGORIES OF SPONSORSHIP Presidential Circle 100,000 and up Platinum 85,000 and up GOLD 60,000 and up SILVER 40,000 and up Bronze 20,000 and up Sponsor 3,000-19,000 [ 15 ]

16 SCIENTIFIC SPONSORSHIP OPPORTUNITIES CONTINUING MEDICAL EDUCATION (CME) APPROVED SESSION 35,000 A company may provide an unrestricted grant to support an existing session of particular interest to the company (see attached Programs in Retina, Anterior Segment, and Glaucoma). Dates: Friday or Saturday. Educational Session Grant includes costs of session hall and basic audiovisual equipment Grant includes costs of 5 Moderators, Chairs, Speakers during that session Advertisement Package One full page color advertisement in the Congress Program Book Brochure in the participants bags Promotion Company logo on regular announcements to Congress Database Provided by the Company Exhibition Exhibition space will be charged at a sponsor rate of 450 per each sq.m Optional Additional Cost Video or and Audio Web Cast Recording of presentation to allow pod cast of session, available on the COPHy Website for up to a year.

17 SCIENTIFIC SPONSORSHIP OPPORTUNITIES ** NEW ** BREAKFAST INDUSTRIAL SYMPOSIUM (NON-CME APPROVED) 40,000 The expenses (travel, accommodation, honorarium, and registration) of the Speakers of a sponsored Industrial Symposium are additional and the responsibility of the Sponsor). A company may organize a Breakfast Industrial (non-cme approved) symposium (60 minutes; from 7:15 AM to 8:15 AM). The topic will be subject to approval by the Chairpersons of the Conference (Drs. Bressler and Loewenstein) and is expected to follow the controversies theme of the meeting. The Speakers or Moderators will be subject to the approval of the Chairpersons so that they can be included in the Scientific Program as either speakers or moderators or both, and should be available for the entire duration of the Scientific Program (Friday, Saturday, and Sunday morning). Dates: Friday or Saturday. Symposium will be before any scientific sessions Educational Session Symposium hall and basic audiovisual equipment Advertisement Package One full page color advertisement in the Congress Program Book Brochure in the participants bags Promotion Optional simultaneous web cast of Symposium Company logo on regular announcements to Congress Database Specially-designed mail shots announcing Industrial Symposium to Sponsor s subsidiaries and affiliates Breakfast A buffet breakfast will be served during the symposium for all the participants. Provided by Company Exhibition Exhibition space will be charged at a sponsor rate of 450 per each sq.m [ 17 ]

18 SCIENTIFIC SPONSORSHIP OPPORTUNITIES PLENARY INDUSTRIAL SYMPOSIUM DURING THE CONGRESS (NON-CME APPROVED) 50,000 A company may organize an industrial non-cme approved symposium (60-90 minutes) during the day with no parallel scientific sessions simultaneously. The topic will be subject to approval by the Chairpersons of the Conference (Drs. Bressler and Loewenstein) and is expected to follow the controversies theme of the meeting. The Speakers or Moderators will be subject to the approval of the Chairpersons so that they can be included in the Scientific Program as either speakers or moderators or both, and should be available for the entire duration of the Scientific Program (Friday, Saturday, and Sunday morning). Dates: Friday or Saturday. Symposium will allocated within a plenary basis hall with no parallel sessions simultaneously. Educational Session Plenary symposium hall and basic audiovisual equipment Advertisement Package One full page color advertisement in the Congress Program Book Brochure in the participants bags Promotion Optional web cast of Symposium Company logo on regular announcements to Congress Database Specially-designed mail shots announcing Industrial Satellite Symposium to Sponsor s subsidiaries and affiliates Provided by Company Exhibition Exhibition space will be charged at a sponsor rate of 450 per each sq.m The expenses (travel, accommodation and registration) of the Chairpersons and Speakers of an Industrial Pre or Post-Congress Satellite Symposium are additional and the responsibility of the Sponsor. YOUNG SCIENTISTS 30,000 Sponsorship of the travel, registration fees and accommodation (up to three nights) of up to 15 young scientists below the age of 40, who will be selected by the Chairpersons, in consultation with relevant Section Heads of Retina, Anterior Segment, or Glaucoma, based on abstracts submitted and accepted. The Sponsor will provide selected scientists with complimentary registrations Names and contact details of selected scientists Representative of the company will be invited to a special ceremony where the winners will be announced and presented with the award. [ 18 ]

19 SCIENTIFIC SPONSORSHIP OPPORTUNITIES NEW PLAYERS ON THE BLOCK 15,000 A company may provide an unrestricted grant for a presentation of minutes on a new drug/product to be included in the New Players session. Session will be part of the CME sessions, part of the Scientific Program. Session hall and basic audiovisual equipment Brochure in the participants bags EUROPEAN SPEAKER 3,000 An unrestricted grant to cover, in part, the expenses of one invited European Speaker. Expenses include travel, accommodation and registration and recognition. One full page color advertisement in the Congress Program Book NORTH AMERICAN, SOUTH AMERICAN, OR ASIAN SPEAKER/S 6,000 An unrestricted grant to cover, in part, the expenses of one invited Speaker. Expenses include travel, accommodation and registration and recognition. One full page color advertisement in the Congress Program Book [ 19 ]

20 ADDITIONAL SPONSORSHIP OPPORTUNITIES LUNCH 15,000 (per lunch) To subsidize, in part, a buffet lunch to be served to all participants of the Congress. Four complimentary registrations One full page color advertisement in the Congress Program Book Brochure in the participants bags WELCOME RECEPTION Sole Sponsorship 10,000 A Welcome Reception for all participants will be held on Thursday evening. Two complimentary registrations 5-minute greeting at the Welcome Reception Company logo on the official invitation Acknowledgment on special board on-site during the Welcome Reception One full page color advertisement in the Congress Program Book Brochure in the participants bags

21 ADDITIONAL SPONSORSHIP OPPORTUNITIES FACULTY DINNER Sole Sponsorship 15,000 A dinner will be held for the invited speakers of the Congress. Two complimentary registrations Two seats at the honorary faculty table 5-minute greeting at the Faculty Dinner Company logo on the official invitation Acknowledgment on special board on-site during the Faculty Dinner One full page color advertisement in the Congress Program Book Brochure in the participants bags SOLD CONGRESS PROGRAM BOOK Sole Sponsorship 15,000 The Congress Program Book will include the Scientific Program and the Scientific Abstracts, and will be distributed to all participants. This sponsorship opportunity is reserved for Presidential Circle, Platinum and Gold Sponsors, and will be available on a first-come, first-served basis. Full page color advertisement on the back cover of the Congress Program Book Additional full page color advertisement in the Congress Program Book INTERNET CENTER Sole Sponsorship 10,000 The Internet Center will be outfitted with internet workstations for participants of the Congress to stay updated between sessions. The Sponsor may: Display logo as a screensaver Display logo on screen background [ 21 ]

22 ADDITIONAL SPONSORSHIP OPPORTUNITIES PARTICIPANTS BAGS Sole Sponsorship provided-in-kind + 10,000 The opportunity to provide branded bags for all participants of the Congress, except where precluded by a participant s regional laws. This sponsorship opportunity is reserved for Presidential Circle, Platinum and Gold Sponsors, and will be available on a first-come, first-served basis. Brochure in the participants bags ABSTRACTS ON THE WEBSITE Sole Sponsorship 8,000 The Scientific Abstracts of the Congress will be placed on the Congress Website and will be available for a limited period. POCKET PROGRAM Sole Sponsorship 8,000 A Pocket Program will be distributed to all participants in their Congress Kits. This sponsorship opportunity is reserved for Presidential Circle, Platinum and Gold Sponsors, and will be available on a first-come, firstserved basis. Exclusive advertisement on the back cover of the Pocket Program Brochure in the participants bags [ 22 ]

23 ADDITIONAL SPONSORSHIP OPPORTUNITIES TRANSLATION 5,000 (per hall, per day) Simultaneous translation from English into any required language. WRITING PADS AND PENS Sole Sponsorship provided-in-kind + 5,000 The opportunity to provide branded writing pads and pens that will be included in the participants bags. Except where precluded by a participant s regional laws. CONGRESS LANYARDS Sole Sponsorship The Sponsor will provide printed lanyards for the name badges 5,000 The Congress will provide printed lanyards for the name badges 8,000 This sponsorship opportunity is reserved for Presidential Circle, Platinum and Gold Sponsors, and will be available on a first-come, first-served basis and will be included at registration, except where precluded by a participant s regional laws. [ 23 ]

24 BROCHURE INSERT 3,000 Company brochure to be inserted into the participants bags, which will be distributed at the Congress. COFFEE BREAK 3,000 (per coffee break) There will be daily coffee breaks between sessions throughout the Congress. TAILOR-MADE SPONSORSHIP PACKAGES Sponsorship packages may be tailored to suit the Sponsor s marketing strategy in order to maximize visibility, and to best promote products and services. Please contact the Congress Organizer for further details on creating the appropriate package. [ 24 ]

25 EXHIBITION An exhibition will be held in conjunction with the Congress. The exhibition floor plan is designed to maximize exposure to the participants. All lunches and coffee breaks will be held in the exhibition area daily. Exhibition space will be available on a first-come, first-served basis, with priority given to Presidential Circle, Platinum and Gold Sponsors. Exhibition space will be available as follows: The cost for exhibition space rental is 650 per sq.m. Companies who will contribute minimum of 25,000 the cost will be entitled to a special sponsors rate of 450 per sq.m. The minimum booth size is 2 x 3 sq.m. Please visit to view the exhibition floor-plan. Exhibition space rental is priced according to size (per sq.m) and includes: Net stand area Company profile in Congress Program Book Two exhibitor registrations Exhibitors Manual General cleaning of public areas Venue security Stand equipment and additional services may be ordered by means of the forms in the Exhibitors Manual: Furniture, partition walls, carpets, telephone and data lines, electricity, stand cleaning, exhibitors insurance, logistics, among other services. Terms and Conditions All sponsorship and exhibition prices quoted are in and are subject to VAT Time slot allocation will be based on level of sponsorship and approval from the Scientific Committee It is the responsibility of the Sponsors and Exhibitors to comply with the regulations of the local authorities, EFPIA (European Federation of Pharmaceutical Industries & Associations) HYPERLINK « org» and IFMPA (International Federation of Pharmaceutical Manufacturers & Associations) HYPERLINK « Code of Practice on the Promotion of Medicines. The Congress Organizers reserves the right to accept or decline offers of sponsorship and application for exhibition space The Congress Organizer reserves the right to amend the published floor plan should it be felt that such an amendment would benefit the exhibition and the Congress as a whole Please note that the Congress Organizer must approve all exhibition stand designs [ 25 ]

26 Exhibition floorplan hall A Height restriction: 3m 14 3x3 hall B 4 4.6x2 8 2x3 7 2x3 13 3x3 12 3x x2 6 2x3 5 2x3 11 3x3 10 3x3 hall C 9 3x3 speakers preview room 1 2x3 2 2x4 MAIN ENTRANCE [ 26 ]

27 GENERAL INFORMATION Congress Venue Intercontinental Budapest Apáczai Csere J. u Budapest, Hungary Language The official language of the Congress is English. Congress Organizer and Sponsorship / Exhibition Contact: 53, Rothschild Boulevard, PO Box 68 Tel Aviv, , Israel Tel: Fax: cophy@comtecmed.com Website: Registration Fees Early Registration Late Registration On-Site Registration until from February 1 from January 31, 2013 until March 18, 2013 March 19, 2013 Participants Physicians and Scientists Residents Nurses and Students Registration fees include: Participation in the scientific sessions, program and abstract book, all printed material of the Congress, participants bag, invitation to the Welcome Reception, coffee breaks, and lunch on Friday and Saturday. Liability and Insurance The Congress Organizer cannot accept liability for personal accidents, or for loss of or damage to private property of participants, either during or directly arising from the Congress. Participants should make their own arrangements with respect to health and travel insurance. [ 27 ]

28 THE ACADEMY FOR CLINICAL DEBATES & CONTROVERSIES IN MEDICINE The 4 th World Congress on CONTROVERSIES IN OPHTHALMOLOGY Anterior Segment Glaucoma Retina cophy@comtecmed.com